Pfizer Strikes Deal with Trump to Lower Medicaid Drug Costs

Key Takeaways

  • Pfizer agreed to a deal with the Trump administration to lower some prescription drug costs

  • The agreement includes 'most-favored-nation' pricing for the Medicaid program and direct-sale website discounts

  • The pricing changes, which face skepticism, could take effect in 2026

Originally published on healthday.com, part of the BLOX Digital Content Exchange.